# Bortezomib

NDC: 75007-501
Generic name: Bortezomib
Labeler / Manufacturer: Ningbo Shuangcheng Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20251217

FDA application: ANDA216528

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75007-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75007-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b17ca681-59a5-4af7-98a4-953b38379893